Skip to main content

Tailored Activity Program-VA

  • Active, not recruiting

This study will test the efficacy of the Tailored Activity Program (TAP-VA), a patient-centric intervention designed to reduce the burden of neuropsychiatric symptoms in veterans with dementia who live at home with family caregivers. An occupational therapist will identify a veteran's preserved capabilities and deficits, as well as previous roles, habits, and interests, then develop activities tailored to the veteran's profile. Family caregivers will be trained to incorporate these activities into daily care routines.

Minimum Age Maximum Age Gender Healthy Volunteers
18 Years N/A Both No
August 2012
November 2015
160

All Participants

++English speaking++If taking psychotropic medication (antidepressants, benzodiazepines, antipsychotics, anticonvulsants, or an anti-dementia medication), must be on a stable dose for 60 days prior to enrollment

Veterans

++Diagnosed with dementia++Ability to participate in at least two activities of daily living (bathing, dressing, grooming, toileting, transferring from bed to chair)

Caregivers

++Primary caregiver living with the veteran++21 years of age or older++Planning to live in area for at least 8 months++Reports one or more neuropsychiatric symptoms in veteran in past month

++Nonveteran++No caregiver available++Currently participating in any other dementia- or caregiver-related intervention

This Phase I study will test the efficacy of the Tailored Activity Program (TAP-VA), a patient-centric intervention designed to reduce the burden of neuropsychiatric symptoms in veterans with dementia who live at home with family caregivers. An occupational therapist will conduct an assessment to identify a veteran's preserved capabilities and deficits, as well as previous roles, habits, and interests, then develop activities tailored to the veteran's profile. Family caregivers will be trained to incorporate these activities into daily care routines. The study involves eight sessions during 4 months in veterans' homes.

Findings from a pilot study of TAP-VA showed statistically significant and clinically meaningful reductions in neuropsychiatric symptoms, specifically agitation and, for caregivers, less time being "on duty." We plan to test TAP-VA in racially and ethnically diverse veterans with dementia and their family caregivers. Pairs will be randomly assigned to receive TAP-VA or an attention control group. They will be evaluated to determine any long-term treatment effects, including continued activity use, caregiver well-being, and costs.

Name City State Zip Status Primary Contact
North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville Florida 32608

Department of Veterans Affairs

Name Role Affiliation
William C. Mann, PhD Principal Investigator North Florida/South Georgia Veterans Health System

Name Phone Extension Email
William C. Mann, PhD 352-376-1611 William.Mann@va.gov

Nonpharmacologic Management of Challenging Behaviors in Veterans with Dementia